BKD

ANALYST NOTE: BKD (Brookdale Senior Living Inc.) Date: 2026-06-13 Current Price: $13.65

1. Structural Readiness

Breakout Level: Not explicitly defined in the provided data points. This is the resistance level that must be cleared to transition the coil from "forming" to "confirmed." Current Price: $13.65. Extension: Not calculated (requires breakout level). ATR Context: Current ATR is 3.8% (productive). This volatility is within the historical "sweet spot" (4–6% is ideal, 3.8% is acceptable for sizing), suggesting the stock is not in a "very high" or "extreme" volatility regime that would typically signal a severe loser or a chaotic breakout environment.

2. Thesis Layer

Thesis Classification: Tactical / Setup-Led. There is no named secular thesis attached to this specific setup at this date. The investment case is not driven by a macro secular theme (e.g., "Silver Tsunami" or "Regulatory Shift") but rather by the quality of the technical structure combined with the company's specific operational fundamentals. The conviction must be derived strictly from the setup quality (the forming coil) and the business fundamentals provided in the evidence, without inventing external narratives.

3. The Business

Company Overview: Brookdale Senior Living Inc. is a premier operator of senior living communities in the United States. As of March 31, 2026, the company operates and manages 568 communities across the U.S. (E8, E10). Business Model & Segments: The company operates through three distinct divisions (E23):

Revenue Mix: The company is heavily reliant on private pay, generating 93.9% of resident fee revenue from private pay residents in 2025, with only 4.8% from government reimbursement programs (E17). Operational Strategy:

• Independent Living: Integrates independent and assisted living units, targeting middle to upper-income seniors (E24).
• Assisted Living and Memory Care: Provides 24-hour assistance and specialized care for dementia/Alzheimer's (E25, E26).
• Continuing Care Retirement Communities (CCRCs): Offers a comprehensive range of living options to allow residents to age-in-place (E27).
• Asset Lightening: The company is actively divesting owned assets to optimize its balance sheet. In Q1 2026, they sold 7 communities (330 units) for $22M. In Q2 2026 (through the earnings date), they sold 3 additional communities (545 units) for $88M (E5, E13).
• Future Divestitures: Management plans to sell 19 additional owned communities (1,438 units) during 2026 (E11). Earlier guidance (Feb 2026) projected selling 29 communities for ~$200M in proceeds (E18).
• Growth Drivers: The company attributes RevPAR growth to annual rate increases (E12) and expects to maintain 8% to 9% RevPAR growth for 2026 (E1, E2).
• Financial Targets: Management expects adjusted EBITDA of $502 million to $516 million for 2026, representing mid-teens growth from the 2025 baseline of $445 million (E1, E2). They also target reducing annualized leverage to below 6x by the end of 2028 (E3).
• Capital Allocation: Projected CapEx spend for 2026 is between $175 million and $195 million (E4).
• Brand Strength: Brookdale has been recognized by U.S. News and World Report as the top operator for five consecutive years, with 294 communities receiving the "Best Senior Living Award" in early April 2026 (E7).

4. Archetype and Conviction

Archetype: Quality Compounder (with elements of a Margin Inflector via asset optimization). Fit Analysis:

• Quality Compounder: The company demonstrates consistent operational excellence (5 consecutive years of top awards), a high-quality revenue mix (93.9% private pay), and a clear path to deleveraging (targeting <6x leverage). The guidance for mid-teens EBITDA growth supports a compounding narrative.
• Margin Inflector: The active divestiture program (selling 19+ communities in 2026) is designed to generate cash proceeds ($200M+ target) to pay down debt, directly improving the balance sheet and reducing interest expense, thereby inflecting margins.
• Valuation Context: The financial spine indicates a forward consensus EPS of -0.154 for FY1 and 0.114 for FY2 (E29). This suggests the market is currently pricing in a near-term earnings dip or normalization before a return to profitability in FY2. The current price of $13.65 reflects this transition.
• Conviction Stack:
• *Thesis Strength:* Low (Tactical only).
• *Evidence Quality:* High (Strong management guidance, clear divestiture track record, strong brand metrics).
• *Structural Quality:* Moderate (Forming coil, not yet confirmed).
• *Rerating Potential:* Moderate to High, contingent on the successful execution of the divestiture plan and the realization of the EBITDA guidance.

5. Invalidations, Strengths, and Gaps

What Would Invalidate the Case:

• Fundamental: A significant miss on the 2026 RevPAR guidance (8-9%) or EBITDA guidance ($502M-$516M).
• Operational: Failure to execute the planned divestitures (selling 19 communities) or a failure to reduce leverage as projected.

What Would Strengthen the Case:

• Fundamental: Reiteration or upward revision of the 2026 guidance, or faster-than-expected deleveraging.
• Operational: Successful closure of the 19 planned community sales, generating the projected $200M+ in proceeds.

Gaps in Evidence:

• Debt Details: While leverage targets are mentioned (<6x), the current specific leverage ratio as of June 2026 is not provided.
• Occupancy Rates: The evidence cites RevPAR growth but does not explicitly state the current occupancy rates or occupancy trends, which are critical for senior living operators.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: medium Key evidence: Management guidance for 8-9% RevPAR growth and $502M-$516M EBITDA in 2026; active divestiture program selling 19+ communities to deleverage; 93.9% private pay revenue mix indicating pricing power. Sizing hint: Position size should be conservative given the "forming" status and negative FY1 EPS consensus; treat as a partial position pending breakout confirmation. Expected path: Management expects to execute the sale of 19 communities in 2026 to generate ~$200M proceeds, reducing leverage to below 6x by 2028 while maintaining mid-teens EBITDA growth. Expected horizon: 6 to 12 months for the divestiture cycle to materially impact the balance sheet and for the technical setup to resolve.